Position in NVS
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$4,005,763
-$293,996 QoQ
Shares Held
25,560
-9.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#303
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MGO ONE SEVEN LLC holds $124,368,544 across 14 Drug Manufacturers - General names. NVS ranks #6 (3.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
25,904 | $31,070,037 | |
| 2 | JNJ |
Johnson & Johnson
|
122,187 | $31,031,832 | |
| 3 | ABBV |
AbbVie Inc.
|
114,011 | $28,689,728 | |
| 4 | MRK |
Merck & Co., Inc.
|
80,447 | $10,337,439 | |
| 5 | AMGN |
Amgen Inc
|
12,437 | $4,503,686 | |
| 6 | NVS |
Novartis AG
This page
|
25,560 | $4,005,763 | |
| 7 | AZN |
Astrazeneca PLC
|
20,123 | $3,815,723 | |
| 8 | PFE |
Pfizer Inc
|
138,195 | $3,327,735 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,005,763 | 25,560 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $4,299,759 | 28,149 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $4,446,858 | 32,254 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $3,374,635 | 26,315 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $2,898,310 | 23,951 | Shares | Sole | 2025-07-25 | |
| 2025-03-31 | $2,598,264 | 23,307 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $2,696,460 | 27,710 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $2,837,313 | 24,668 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $2,815,547 | 26,447 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $2,619,158 | 27,077 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $3,429,547 | 33,966 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $3,250,556 | 31,912 | Shares | Sole | 2023-11-03 | |
| 2023-06-30 | $3,321,654 | 32,917 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $3,148,056 | 34,218 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $2,989,677 | 32,955 | Shares | Sole | 2023-01-25 | |
| 2022-09-30 | $2,355,549 | 30,990 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,356,020 | 27,872 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $2,856,964 | 32,558 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $2,880,387 | 32,930 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $2,785,672 | 34,063 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $3,126,247 | 34,264 | Shares | Sole | 2021-07-29 | |
| 2021-03-31 | $2,933,930 | 34,323 | Shares | Sole | 2021-04-29 | |
| 2020-12-31 | $3,934,048 | 41,661 | Shares | Sole | 2021-01-22 | |
| 2020-09-30 | $3,727,975 | 42,870 | Shares | Sole | 2020-10-30 | |
| 2020-06-30 | $3,996,241 | 45,755 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $3,369,978 | 40,873 | Shares | Sole | 2020-04-17 | |
| No filing history on record for this holder in this stock. | ||||||